Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Ragaglitazar: the pharmacokinetics, pharmacodynamics, and tolerability of a novel dual PPAR alpha and gamma agonist in healthy subjects and patients with type 2 diabetes.

Skrumsager BK, Nielsen KK, Müller M, Pabst G, Drake PG, Edsberg B.

J Clin Pharmacol. 2003 Nov;43(11):1244-56.

PMID:
14551179
3.

Structural and evolutionary relationships among protein tyrosine phosphatase domains.

Andersen JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, Jansen PG, Andersen HS, Tonks NK, Møller NP.

Mol Cell Biol. 2001 Nov;21(21):7117-36. Review. No abstract available.

4.

Association of phosphatidylinositol 3-kinase with the insulin receptor: compartmentation in rat liver.

Drake PG, Balbis A, Wu J, Bergeron JJ, Posner BI.

Am J Physiol Endocrinol Metab. 2000 Aug;279(2):E266-74.

5.

Insulin receptor-associated protein tyrosine phosphatase(s): role in insulin action.

Drake PG, Posner BI.

Mol Cell Biochem. 1998 May;182(1-2):79-89. Review.

PMID:
9609117
6.

Insulin receptor internalization and signalling.

Di Guglielmo GM, Drake PG, Baass PC, Authier F, Posner BI, Bergeron JJ.

Mol Cell Biochem. 1998 May;182(1-2):59-63. Review.

PMID:
9609114
7.

A role for tyrosine phosphorylation in both activation and inhibition of the insulin receptor tyrosine kinase in vivo.

Drake PG, Bevan AP, Burgess JW, Bergeron JJ, Posner BI.

Endocrinology. 1996 Nov;137(11):4960-8.

PMID:
8895369
8.

Intracellular signal transduction: The role of endosomes.

Bevan AP, Drake PG, Bergeron JJ, Posner BI.

Trends Endocrinol Metab. 1996 Jan-Feb;7(1):13-21.

PMID:
18406720
9.

Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis.

Bevan AP, Drake PG, Yale JF, Shaver A, Posner BI.

Mol Cell Biochem. 1995 Dec 6-20;153(1-2):49-58. Review.

PMID:
8927047
10.

Selective activation of the rat hepatic endosomal insulin receptor kinase. Role for the endosome in insulin signaling.

Bevan AP, Burgess JW, Drake PG, Shaver A, Bergeron JJ, Posner BI.

J Biol Chem. 1995 May 5;270(18):10784-91.

11.
12.

In vivo insulin mimetic effects of pV compounds: role for tissue targeting in determining potency.

Bevan AP, Burgess JW, Yale JF, Drake PG, Lachance D, Baquiran G, Shaver A, Posner BI.

Am J Physiol. 1995 Jan;268(1 Pt 1):E60-6. Erratum in: Am J Physiol 1996 Jan;20(1 Pt 1):section E followi.

PMID:
7840184

Supplemental Content

Loading ...
Support Center